{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:51:17Z","timestamp":1788954677839,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Research Project of the Second Affiliated Hospital of Guangzhou Medical University","award":["2021-LCYJ-DZX-03\uff0c2022-LCYJ-YYDZX-03"],"award-info":[{"award-number":["2021-LCYJ-DZX-03\uff0c2022-LCYJ-YYDZX-03"]}]},{"name":"the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital","award":["202201-304"],"award-info":[{"award-number":["202201-304"]}]},{"name":"Second Affiliated Hospital of Guangzhou Medical University Fund Project","award":["2021-LCYJ-04"],"award-info":[{"award-number":["2021-LCYJ-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02522-9","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:30:42Z","timestamp":1742581842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of the remnant cholesterol to high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Zebin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingdong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2522_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneph.2017.84","volume":"13","author":"S Sharma","year":"2017","unstructured":"Sharma S, Sarnak MJ, Epidemiology. The global burden of reduced GFR: ESRD, CVD and mortality. Nat Rev Nephrol. 2017;13:447\u20138.","journal-title":"Nat Rev Nephrol"},{"key":"2522_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal Dialysis use and practice patterns: an international survey study. Am J Kidney Dis Off J Natl Kidney Found. 2021;77:315\u201325.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"2522_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY-M, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696\u2013707.","journal-title":"Nat Rev Nephrol"},{"key":"2522_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ccl.2021.04.008","volume":"39","author":"A Thobani","year":"2021","unstructured":"Thobani A, Jacobson TA. Dyslipidemia in patients with kidney disease. Cardiol Clin. 2021;39:353\u201363.","journal-title":"Cardiol Clin"},{"key":"2522_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IJNRD.S101808","volume":"10","author":"I Mikolasevic","year":"2017","unstructured":"Mikolasevic I, \u017dutelija M, Mavrinac V, Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renov Dis. 2017;10:35\u201345.","journal-title":"Int J Nephrol Renov Dis"},{"key":"2522_CR6","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","volume":"365","author":"AIM-HIGH Investigators","year":"2011","unstructured":"Investigators AIM-HIGH, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, et al. Niacin in patients with low HDL cholesterol levels receiving intensive Statin therapy. N Engl J Med. 2011;365:2255\u201367.","journal-title":"N Engl J Med"},{"key":"2522_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Bor\u00e9n J, Catapano AL, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32:1345\u201361.","journal-title":"Eur Heart J"},{"key":"2522_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet Lond Engl. 2014;384:626\u201335.","journal-title":"Lancet Lond Engl"},{"key":"2522_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12944-023-01943-8","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zha F, Han Y, Cai Y, Chen M, Yang C, et al. Nonlinear connection between remnant cholesterol and stroke risk: evidence from the China health and retirement longitudinal study. Lipids Health Dis. 2023;22:181.","journal-title":"Lipids Health Dis"},{"key":"2522_CR10","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1161\/STROKEAHA.121.037756","volume":"53","author":"W Li","year":"2022","unstructured":"Li W, Huang Z, Fang W, Wang X, Cai Z, Chen G, et al. Remnant cholesterol variability and incident ischemic stroke in the general population. Stroke. 2022;53:1934\u201341.","journal-title":"Stroke"},{"key":"2522_CR11","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/clinem\/dgab337","volume":"106","author":"D Yu","year":"2021","unstructured":"Yu D, Wang Z, Zhang X, Qu B, Cai Y, Ma S, et al. Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy. J Clin Endocrinol Metab. 2021;106:3546\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"2522_CR12","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","volume":"76","author":"O Casta\u00f1er","year":"2020","unstructured":"Casta\u00f1er O, Pint\u00f3 X, Subirana I, Amor AJ, Ros E, Hern\u00e1ez \u00c1, et al. Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76:2712\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"2522_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.numecd.2023.02.009","volume":"33","author":"J Deng","year":"2023","unstructured":"Deng J, Tang R, Chen J, Zhou Q, Zhan X, Long H, et al. Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal Dialysis patients. Nutr Metab Cardiovasc Dis. 2023;33:1049\u201356.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2522_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.archger.2010.03.022","volume":"52","author":"EV de Freitas","year":"2011","unstructured":"de Freitas EV, Brand\u00e3o AA, Pozzan R, Magalh\u00e3es ME, Fonseca F, Pizzi O, et al. Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly. Arch Gerontol Geriatr. 2011;52:217\u201322.","journal-title":"Arch Gerontol Geriatr"},{"key":"2522_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12882-022-02932-2","volume":"23","author":"M Weldegiorgis","year":"2022","unstructured":"Weldegiorgis M, Woodward M. Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the united Kingdom. BMC Nephrol. 2022;23:312.","journal-title":"BMC Nephrol"},{"key":"2522_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12944-020-01336-1","volume":"19","author":"W-S Yang","year":"2020","unstructured":"Yang W-S, Li R, Shen Y-Q, Wang X-C, Liu Q-J, Wang H-Y, et al. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Lipids Health Dis. 2020;19:160.","journal-title":"Lipids Health Dis"},{"key":"2522_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jjcc.2016.12.010","volume":"70","author":"R-X Zeng","year":"2017","unstructured":"Zeng R-X, Li S, Zhang M-Z, Li X-L, Zhu C-G, Guo Y-L, et al. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes. J Cardiol. 2017;70:113\u201320.","journal-title":"J Cardiol"},{"key":"2522_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12876-022-02216-x","volume":"22","author":"Y Zou","year":"2022","unstructured":"Zou Y, Hu C, Kuang M, Chai Y. Remnant cholesterol\/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease. BMC Gastroenterol. 2022;22:134.","journal-title":"BMC Gastroenterol"},{"key":"2522_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/eurjpc\/zwac286","volume":"30","author":"A Cordero","year":"2023","unstructured":"Cordero A, Alvarez-Alvarez B, Escribano D, Garc\u00eda-Acu\u00f1a JM, Cid-Alvarez B, Rodr\u00edguez-Ma\u00f1ero M, et al. Remnant cholesterol in patients admitted for acute coronary syndromes. Eur J Prev Cardiol. 2023;30:340\u20138.","journal-title":"Eur J Prev Cardiol"},{"key":"2522_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1373\/clinchem.2015.253757","volume":"62","author":"A-MK Jepsen","year":"2016","unstructured":"Jepsen A-MK, Langsted A, Varbo A, Bang LE, Kamstrup PR, Nordestgaard BG. Increased remnant cholesterol explains part of residual risk of All-Cause mortality in 5414 patients with ischemic heart disease. Clin Chem. 2016;62:593\u2013604.","journal-title":"Clin Chem"},{"key":"2522_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","volume":"61","author":"A Varbo","year":"2015","unstructured":"Varbo A, Freiberg JJ, Nordestgaard BG. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population. Clin Chem. 2015;61:533\u201343.","journal-title":"Clin Chem"},{"key":"2522_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1159\/000144024","volume":"28","author":"V Tsimihodimos","year":"2008","unstructured":"Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol. 2008;28:958\u201373.","journal-title":"Am J Nephrol"},{"key":"2522_CR23","first-page":"2696","volume":"25","author":"RA Ghayda","year":"2021","unstructured":"Ghayda RA, Lee JY, Yang JW, Han CH, Jeong GH, Yoon S, et al. The effect of Statins on all-cause and cardiovascular mortality in patients with non-dialysis chronic kidney disease, patients on dialysis, and kidney transplanted recipients: an umbrella review of meta-analyses. Eur Rev Med Pharmacol Sci. 2021;25:2696\u2013710.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2522_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299\u2013308.","journal-title":"JAMA"},{"key":"2522_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, J\u00f8rgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61:427\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"2522_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12933-020-01076-7","volume":"19","author":"Y-X Cao","year":"2020","unstructured":"Cao Y-X, Zhang H-W, Jin J-L, Liu H-H, Zhang Y, Gao Y, et al. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol. 2020;19:104.","journal-title":"Cardiovasc Diabetol"},{"key":"2522_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12944-024-02241-7","volume":"23","author":"M Li","year":"2024","unstructured":"Li M, Liu Q, Shi M, Fu M, He G. Association between remnant cholesterol and the risk of 4 site-specific cancers: evidence from a cross-sectional and Mendelian randomization study. Lipids Health Dis. 2024;23:256.","journal-title":"Lipids Health Dis"},{"key":"2522_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.scib.2023.12.035","volume":"69","author":"Y Tian","year":"2024","unstructured":"Tian Y, Wu Y, Qi M, Song L, Chen B, Wang C, et al. Associations of remnant cholesterol with cardiovascular and cancer mortality in a nationwide cohort. Sci Bull. 2024;69:526\u201334.","journal-title":"Sci Bull"},{"key":"2522_CR29","doi-asserted-by":"publisher","first-page":"17584","DOI":"10.1038\/s41598-022-21177-5","volume":"12","author":"B Fabre","year":"2022","unstructured":"Fabre B, Fernandez Machulsky N, Olano C, Jacobsen D, G\u00f3mez ME, Perazzi B, et al. Remnant cholesterol levels are associated with severity and death in COVID-19 patients. Sci Rep. 2022;12:17584.","journal-title":"Sci Rep"},{"key":"2522_CR30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","volume":"37","author":"SJ Bernelot Moens","year":"2017","unstructured":"Bernelot Moens SJ, Verweij SL, Schnitzler JG, Stiekema LCA, Bos M, Langsted A, et al. Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans. Arterioscler Thromb Vasc Biol. 2017;37:969\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2522_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/MED.0000000000000393","volume":"25","author":"K Nakajima","year":"2018","unstructured":"Nakajima K, Tanaka A. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis. Curr Opin Endocrinol Diabetes Obes. 2018;25:108\u201317.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2522_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2018.12.014","volume":"490","author":"H Tada","year":"2019","unstructured":"Tada H, Nohara A, Inazu A, Mabuchi H, Kawashiri M-A. Remnant lipoproteins and atherosclerotic cardiovascular disease. Clin Chim Acta Int J Clin Chem. 2019;490:1\u20135.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"2522_CR33","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"key":"2522_CR34","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1681\/ASN.2017070798","volume":"29","author":"F Kronenberg","year":"2018","unstructured":"Kronenberg F. HDL in CKD-The devil is in the detail. J Am Soc Nephrol JASN. 2018;29:1356\u201371.","journal-title":"J Am Soc Nephrol JASN"},{"key":"2522_CR35","doi-asserted-by":"publisher","first-page":"155817","DOI":"10.1016\/j.metabol.2024.155817","volume":"154","author":"J-X Chen","year":"2024","unstructured":"Chen J-X, Li Y, Zhang Y-B, Wang Y, Zhou Y-F, Geng T, et al. Nonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: an observational and Mendelian randomization analysis. Metabolism. 2024;154:155817.","journal-title":"Metabolism"},{"key":"2522_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.athplu.2023.04.001","volume":"52","author":"C Pavanello","year":"2023","unstructured":"Pavanello C, Ossoli A. HDL and chronic kidney disease. Atheroscler Plus. 2023;52:9\u201317.","journal-title":"Atheroscler Plus"},{"key":"2522_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/MCA.0000000000001320","volume":"35","author":"L Pan","year":"2024","unstructured":"Pan L, Jiang W, Liao L, Li W, Wang F. Association between the remnant cholesterol to high-density lipoprotein cholesterol ratio and the risk of coronary artery disease. Coron Artery Dis. 2024;35:114\u201321.","journal-title":"Coron Artery Dis"},{"key":"2522_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/01.ATV.13.1.33","volume":"13","author":"B Lamarche","year":"1993","unstructured":"Lamarche B, Despr\u00e9s JP, Pouliot MC, Prud\u2019homme D, Moorjani S, Lupien PJ, et al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb J Vasc Biol. 1993;13:33\u201340.","journal-title":"Arterioscler Thromb J Vasc Biol"},{"key":"2522_CR39","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1172\/JCI5286","volume":"103","author":"B Lamarche","year":"1999","unstructured":"Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL Apo A-I in healthy men. J Clin Invest. 1999;103:1191\u20139.","journal-title":"J Clin Invest"},{"key":"2522_CR40","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1172\/JCI116384","volume":"91","author":"BS Horowitz","year":"1993","unstructured":"Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN. Increased plasma and renal clearance of an exchangeable pool of Apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 1993;91:1743\u201352.","journal-title":"J Clin Invest"},{"key":"2522_CR41","doi-asserted-by":"publisher","first-page":"909373","DOI":"10.1155\/2014\/909373","volume":"2014","author":"Y Cho","year":"2014","unstructured":"Cho Y, Hawley CM, Johnson DW. Clinical causes of inflammation in peritoneal Dialysis patients. Int J Nephrol. 2014;2014:909373.","journal-title":"Int J Nephrol"},{"key":"2522_CR42","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms232112906","volume":"23","author":"MY Henein","year":"2022","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. Int J Mol Sci. 2022;23:12906.","journal-title":"Int J Mol Sci"},{"key":"2522_CR43","doi-asserted-by":"publisher","first-page":"2361094","DOI":"10.1080\/0886022X.2024.2361094","volume":"46","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Hu X, Zhang S, Wang W, Yu B, Zhou Y, et al. Remnant cholesterol, preinflammatory state and chronic kidney disease: association and mediation analyses. Ren Fail. 2024;46:2361094.","journal-title":"Ren Fail"},{"key":"2522_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbalip.2014.07.015","volume":"1851","author":"L Calabresi","year":"2015","unstructured":"Calabresi L, Gomaraschi M, Simonelli S, Bernini F, Franceschini G. HDL and atherosclerosis: insights from inherited HDL disorders. Biochim Biophys Acta. 2015;1851:13\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"2522_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.krcp.2015.12.007","volume":"35","author":"WK Lo","year":"2016","unstructured":"Lo WK. Metabolic syndrome and obesity in peritoneal Dialysis. Kidney Res Clin Pract. 2016;35:10\u20134.","journal-title":"Kidney Res Clin Pract"},{"key":"2522_CR46","first-page":"e61201","volume":"16","author":"A Sanguankeo","year":"2018","unstructured":"Sanguankeo A, Upala S. Metabolic syndrome increases mortality risk in Dialysis patients: A systematic review and Meta-Analysis. Int J Endocrinol Metab. 2018;16:e61201.","journal-title":"Int J Endocrinol Metab"},{"key":"2522_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jdiacomp.2018.10.018","volume":"33","author":"KA Young","year":"2019","unstructured":"Young KA, Maturu A, Lorenzo C, Langefeld CD, Wagenknecht LE, Chen Y-DI, et al. The triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a predictor of insulin resistance, \u03b2-cell function, and diabetes in Hispanics and African Americans. J Diabetes Complications. 2019;33:118\u201322.","journal-title":"J Diabetes Complications"},{"key":"2522_CR48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diabres.2017.11.011","volume":"135","author":"M Zhang","year":"2018","unstructured":"Zhang M, Zhou J, Liu Y, Sun X, Luo X, Han C, et al. Risk of type 2 diabetes mellitus associated with plasma lipid levels: the rural Chinese cohort study. Diabetes Res Clin Pract. 2018;135:150\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"2522_CR49","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.2215\/CJN.01050211","volume":"6","author":"MZ Molnar","year":"2011","unstructured":"Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar-Zadeh K. Association of hemoglobin and survival in peritoneal Dialysis patients. Clin J Am Soc Nephrol CJASN. 2011;6:1973\u201381.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"2522_CR50","doi-asserted-by":"crossref","unstructured":"Shi X, Feng K. Hypertriglyceridemia interferes with hemoglobin detection and calibration methods. Clin Lab. 2024;70.","DOI":"10.7754\/Clin.Lab.2024.240316"},{"key":"2522_CR51","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/ki.2012.136","volume":"82","author":"BM Robinson","year":"2012","unstructured":"Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, et al. Blood pressure levels and mortality risk among Hemodialysis patients in the Dialysis outcomes and practice patterns study. Kidney Int. 2012;82:570\u201380.","journal-title":"Kidney Int"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02522-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02522-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02522-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T03:17:37Z","timestamp":1742786257000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02522-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2522"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02522-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Second Affiliated Hospital of Guangzhou Medical University (approval number 2024-hg-ks-10) and the 1964 Helsinki Declaration as well as its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors gave their consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}